273 related articles for article (PubMed ID: 21336308)
21. Key mediators of intracellular amino acids signaling to mTORC1 activation.
Duan Y; Li F; Tan K; Liu H; Li Y; Liu Y; Kong X; Tang Y; Wu G; Yin Y
Amino Acids; 2015 May; 47(5):857-67. PubMed ID: 25701492
[TBL] [Abstract][Full Text] [Related]
22. Rheb protein binds CAD (carbamoyl-phosphate synthetase 2, aspartate transcarbamoylase, and dihydroorotase) protein in a GTP- and effector domain-dependent manner and influences its cellular localization and carbamoyl-phosphate synthetase (CPSase) activity.
Sato T; Akasu H; Shimono W; Matsu C; Fujiwara Y; Shibagaki Y; Heard JJ; Tamanoi F; Hattori S
J Biol Chem; 2015 Jan; 290(2):1096-105. PubMed ID: 25422319
[TBL] [Abstract][Full Text] [Related]
23. The GST-BHMT assay reveals a distinct mechanism underlying proteasome inhibition-induced macroautophagy in mammalian cells.
Rui YN; Xu Z; Chen Z; Zhang S
Autophagy; 2015; 11(5):812-32. PubMed ID: 25984893
[TBL] [Abstract][Full Text] [Related]
24. The FoxO-BNIP3 axis exerts a unique regulation of mTORC1 and cell survival under energy stress.
Lin A; Yao J; Zhuang L; Wang D; Han J; Lam EW; Gan B
Oncogene; 2014 Jun; 33(24):3183-94. PubMed ID: 23851496
[TBL] [Abstract][Full Text] [Related]
25. Huntingtin promotes mTORC1 signaling in the pathogenesis of Huntington's disease.
Pryor WM; Biagioli M; Shahani N; Swarnkar S; Huang WC; Page DT; MacDonald ME; Subramaniam S
Sci Signal; 2014 Oct; 7(349):ra103. PubMed ID: 25351248
[TBL] [Abstract][Full Text] [Related]
26. Point mutations of the mTOR-RHEB pathway in renal cell carcinoma.
Ghosh AP; Marshall CB; Coric T; Shim EH; Kirkman R; Ballestas ME; Ikura M; Bjornsti MA; Sudarshan S
Oncotarget; 2015 Jul; 6(20):17895-910. PubMed ID: 26255626
[TBL] [Abstract][Full Text] [Related]
27. Ciclopirox olamine inhibits mTORC1 signaling by activation of AMPK.
Zhou H; Shang C; Wang M; Shen T; Kong L; Yu C; Ye Z; Luo Y; Liu L; Li Y; Huang S
Biochem Pharmacol; 2016 Sep; 116():39-50. PubMed ID: 27396756
[TBL] [Abstract][Full Text] [Related]
28. Rheb regulates nuclear mTORC1 activity independent of farnesylation.
Zhong Y; Zhou X; Guan KL; Zhang J
Cell Chem Biol; 2022 Jun; 29(6):1037-1045.e4. PubMed ID: 35294906
[TBL] [Abstract][Full Text] [Related]
29. Ral and Rheb GTPase activating proteins integrate mTOR and GTPase signaling in aging, autophagy, and tumor cell invasion.
Martin TD; Chen XW; Kaplan RE; Saltiel AR; Walker CL; Reiner DJ; Der CJ
Mol Cell; 2014 Jan; 53(2):209-20. PubMed ID: 24389102
[TBL] [Abstract][Full Text] [Related]
30. Amino acid signalling upstream of mTOR.
Jewell JL; Russell RC; Guan KL
Nat Rev Mol Cell Biol; 2013 Mar; 14(3):133-9. PubMed ID: 23361334
[TBL] [Abstract][Full Text] [Related]
31. Design of negative-regulating proteins of Rheb/mTORC1 with much-reduced sizes of the tuberous sclerosis protein complex.
Fu W; Wu G
Protein Sci; 2023 Aug; 32(8):e4731. PubMed ID: 37462942
[TBL] [Abstract][Full Text] [Related]
32. Computational analysis of an autophagy/translation switch based on mutual inhibition of MTORC1 and ULK1.
Szymańska P; Martin KR; MacKeigan JP; Hlavacek WS; Lipniacki T
PLoS One; 2015; 10(3):e0116550. PubMed ID: 25761126
[TBL] [Abstract][Full Text] [Related]
33. mTOR direct interactions with Rheb-GTPase and raptor: sub-cellular localization using fluorescence lifetime imaging.
Yadav RB; Burgos P; Parker AW; Iadevaia V; Proud CG; Allen RA; O'Connell JP; Jeshtadi A; Stubbs CD; Botchway SW
BMC Cell Biol; 2013 Jan; 14():3. PubMed ID: 23311891
[TBL] [Abstract][Full Text] [Related]
34. Rheb and Rags come together at the lysosome to activate mTORC1.
Groenewoud MJ; Zwartkruis FJ
Biochem Soc Trans; 2013 Aug; 41(4):951-5. PubMed ID: 23863162
[TBL] [Abstract][Full Text] [Related]
35. Ceramide inhibits insulin-stimulated Akt phosphorylation through activation of Rheb/mTORC1/S6K signaling in skeletal muscle.
Hsieh CT; Chuang JH; Yang WC; Yin Y; Lin Y
Cell Signal; 2014 Jul; 26(7):1400-8. PubMed ID: 24650522
[TBL] [Abstract][Full Text] [Related]
36. Evaluating the mTOR Pathway in Physiological and Pharmacological Settings.
Hong S; Inoki K
Methods Enzymol; 2017; 587():405-428. PubMed ID: 28253969
[TBL] [Abstract][Full Text] [Related]
37. Identification of mechanically regulated phosphorylation sites on tuberin (TSC2) that control mechanistic target of rapamycin (mTOR) signaling.
Jacobs BL; McNally RM; Kim KJ; Blanco R; Privett RE; You JS; Hornberger TA
J Biol Chem; 2017 Apr; 292(17):6987-6997. PubMed ID: 28289099
[TBL] [Abstract][Full Text] [Related]
38. Arf5-mediated regulation of mTORC1 at the plasma membrane.
Makhoul C; Houghton FJ; Hinde E; Gleeson PA
Mol Biol Cell; 2023 Apr; 34(4):ar23. PubMed ID: 36735494
[TBL] [Abstract][Full Text] [Related]
39. A posttranslational modification cascade involving p38, Tip60, and PRAK mediates oncogene-induced senescence.
Zheng H; Seit-Nebi A; Han X; Aslanian A; Tat J; Liao R; Yates JR; Sun P
Mol Cell; 2013 Jun; 50(5):699-710. PubMed ID: 23685072
[TBL] [Abstract][Full Text] [Related]
40. Activation of the AMP-activated protein kinase-p38 MAP kinase pathway mediates apoptosis induced by conjugated linoleic acid in p53-mutant mouse mammary tumor cells.
Hsu YC; Meng X; Ou L; Ip MM
Cell Signal; 2010 Apr; 22(4):590-9. PubMed ID: 19932174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
